Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era.
暂无分享,去创建一个
[1] W. Schaffner,et al. Racial and Regional Differences in Rates of Invasive Pneumococcal Disease , 2015, Pediatrics.
[2] M. G. Bupp. Sex, the aging immune system, and chronic disease. , 2015 .
[3] W. Schaffner,et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. , 2015, The Lancet. Infectious diseases.
[4] M. Altfeld,et al. Sex differences in infectious diseases-common but neglected. , 2014, The Journal of infectious diseases.
[5] P. Goulder,et al. Sex Differences in Pediatric Infectious Diseases , 2014, The Journal of infectious diseases.
[6] Á. Gentile. [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination]. , 2014, Archivos argentinos de pediatria.
[7] S. Pelton,et al. Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] W. Schaffner,et al. Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] S. Kaplan,et al. Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine , 2013, The Pediatric infectious disease journal.
[10] T. Lieu,et al. Healthcare utilization and cost of pneumococcal disease in the United States. , 2011, Vaccine.
[11] C. Whitney,et al. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[12] W. Schaffner,et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.
[13] S. Dowell,et al. Holiday spikes in pneumococcal disease among older adults. , 2009, The New England journal of medicine.
[14] J. Stockman. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis , 2009 .
[15] A. Reunanen,et al. Effects of Ageing and Gender on Naturally Acquired Antibodies to Pneumococcal Capsular Polysaccharides and Virulence-Associated Proteins , 2008, Clinical and Vaccine Immunology.
[16] W. Schaffner,et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. , 2008, The Journal of infectious diseases.
[17] Susan S. Huang,et al. Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine , 2007, The Pediatric infectious disease journal.
[18] P. Formenty,et al. Addressing sex and gender in epidemic-prone infectious diseases , 2007 .
[19] W. Schaffner,et al. Elimination of Racial Differences in Invasive Pneumococcal Disease in Young Children After Introduction of the Conjugate Pneumococcal Vaccine , 2004, The Pediatric infectious disease journal.
[20] S. Schrag,et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. , 2004, JAMA.
[21] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.
[22] M. Leinonen,et al. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland , 1997, Epidemiology and Infection.
[23] A J Hall,et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] M. Leinonen,et al. Epidemiology of invasive pneumococcal infections in children in Finland. , 1992, JAMA.
[25] R. Norrby,et al. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. , 1985, Reviews of infectious diseases.
[26] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.